Does PALIVIZUMAB Cause Respiratory syncytial virus infection? 1,692 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,692 reports of Respiratory syncytial virus infection have been filed in association with PALIVIZUMAB (Synagis). This represents 14.8% of all adverse event reports for PALIVIZUMAB.
1,692
Reports of Respiratory syncytial virus infection with PALIVIZUMAB
14.8%
of all PALIVIZUMAB reports
47
Deaths
1,321
Hospitalizations
How Dangerous Is Respiratory syncytial virus infection From PALIVIZUMAB?
Of the 1,692 reports, 47 (2.8%) resulted in death, 1,321 (78.1%) required hospitalization, and 26 (1.5%) were considered life-threatening.
Is Respiratory syncytial virus infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALIVIZUMAB. However, 1,692 reports have been filed with the FAERS database.
What Other Side Effects Does PALIVIZUMAB Cause?
Pyrexia (1,055)
Death (856)
Bronchiolitis (724)
Cough (665)
Pneumonia (657)
Dyspnoea (466)
Nasopharyngitis (462)
Vomiting (445)
Influenza (398)
Product dose omission issue (381)
What Other Drugs Cause Respiratory syncytial virus infection?
LENALIDOMIDE (355)
DUPILUMAB (261)
CYCLOPHOSPHAMIDE (201)
ADALIMUMAB (186)
PREDNISONE (186)
METHOTREXATE (182)
POMALIDOMIDE (181)
HUMAN IMMUNOGLOBULIN G (174)
TACROLIMUS (163)
DEXAMETHASONE (160)
Which PALIVIZUMAB Alternatives Have Lower Respiratory syncytial virus infection Risk?
PALIVIZUMAB vs PALONOSETRON
PALIVIZUMAB vs PAMIDRONATE
PALIVIZUMAB vs PAMIDRONIC ACID
PALIVIZUMAB vs PANCRELIPASE
PALIVIZUMAB vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE